beth israel deaconess medical center a harvard medical school teaching hospital

To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger


  • Rosenberg L, Nanda KS, Zenlea T, Gifford A, Lawlor GO, Falchuk KR, Wolf JL, Cheifetz AS, Goldsmith JD, Moss AC. Histologic Markers of Inflammation in Patients with Ulcerative Colitis in Clinical Remission. Clin Gastroenterol Hepatol. 2013 Apr 13. doi:pii: S1542-3565(13)00460-6. 10.1016/j.cgh.2013.02.030. Epub ahead of print] PubMed PMID: 23591275.


  • Moss AC. Prevention of postoperative recurrence of Crohn's disease: what does the evidence support? Inflamm Bowel Dis. 2013 Mar-Apr;19(4):856-9. doi: 10.1097/MIB.0b013e3182802c21. PubMed PMID: 23446339.


  • Rosenberg L, Lawlor GO, Zenlea T, Goldsmith JD, Gifford A, Falchuk KR, Wolf JL, Cheifetz AS, Robson SC, Moss AC. Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission. Inflamm Bowel Dis. 2013 Mar-Apr;19(4):779-84. doi: 10.1097/MIB.0b013e3182802b0e. PubMed PMID: 23446338.


  • Feuerstein JD, Akbari M, Gifford AE, Cullen G, Leffler DA, Sheth SG, Cheifetz AS. Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines. Aliment Pharmacol Ther. 2013 May;37(10):937-46. doi: 10.1111/apt.12290. Epub 2013 Apr 2. PubMed PMID: 23550536.


  • Lahiff C, Safaie P, Awais A, Akbari M, Gashin L, Sheth S, Lembo A, Leffler D, Moss AC, Cheifetz AS. The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2013 Apr;37(8):786-94. doi: 10.1111/apt.12262. Epub 2013 Feb 21. PubMed PMID: 23432394.


  • Cullen G, Donnellan F, Doherty GA, Smith M, Cheifetz AS. Evaluation of the small bowel in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2013 Mar;7(3):239-51. doi: 10.1586/egh.13.11. PubMed PMID: 23445233


  • Nanda K, Moss A. Erratum: Update on the management of ulcerative colitis:treatment and maintenance approaches focused on MMX(®) mesalamine. [Corrigendum].Clin Pharmacol. 2013;5:21. Epub 2013 Jan 22. PubMed PMID: 23378789; PubMedCentral PMCID: PMC3558314.


  • Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE. Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Mar;19(3):534-9. doi: 10.1097/MIB.0b013e3182802a3c. PubMed PMID: 23429444


  • Gifford AE, Berg AH, Lahiff C, Cheifetz AS, Horowitz G, Moss AC. A random urine test can identify patients at risk of mesalamine non-adherence: a prospective study. Am J Gastroenterol. 2013 Feb;108(2):249-55. doi: 10.1038/ajg.2012.419. Epub 2013 Jan 8. PubMed PMID: 23295279.


  • Nanda KS, Cheifetz AS, Moss AC. Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis. Am J Gastroenterol.

Contact Information

Inflammatory Bowel Disease Program
Digestive Disease Center
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215